Evolus, Inc. (EOLS): Price and Financial Metrics

Evolus, Inc. (EOLS)

Today's Latest Price: $13.97 USD

0.17 (-1.20%)

Updated Nov 21 6:55pm

Add EOLS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EOLS Stock Summary

  • Evolus Inc's stock had its IPO on February 8, 2018, making it an older stock than merely 3.7% of US equities in our set.
  • EOLS's price/sales ratio is 27.23; that's higher than the P/S ratio of 96.06% of US stocks.
  • Revenue growth over the past 12 months for Evolus Inc comes in at 569.75%, a number that bests 98.77% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Evolus Inc, a group of peers worth examining would be APHA, ADES, MNKD, QD, and BBU.
  • Visit EOLS's SEC page to see the company's official filings. To visit the company's web site, go to www.evolus.com.
EOLS Daily Price Range
EOLS 52-Week Price Range

EOLS Stock Price Chart More Charts

EOLS Price/Volume Stats

Current price $13.97
Prev. close $14.14
Day low $13.75
Day high $14.05
50-day MA $15.56
200-day MA $18.75
52-week high $30.25
52-week low $10.22
Volume 424,400
Avg. volume 767,077
Dividend yield N/A
Market Cap 466.95M

Evolus, Inc. (EOLS) Company Bio

Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.

EOLS Latest News Stream

Event/Time News Detail
Loading, please wait...

EOLS Latest Social Stream

Loading social stream, please wait...

View Full EOLS Social Stream

EOLS Price Returns

1-mo -16.10%
3-mo -6.62%
6-mo -13.12%
1-year -4.97%
3-year N/A
5-year N/A
YTD 17.39%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4604 seconds.